Skip to content

Second Opinions in Oncology - A Quantitative and Qualitative Study on Decision-Making and Utilization Processes, Barriers, and Support Needs from the Patient’s Perspective

Second Opinions in Oncology - A Quantitative and Qualitative Study on Decision-Making and Utilization Processes, Barriers, and Support Needs from the Patient’s Perspective - SO-ONC

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00039683
Enrollment
1200
Registered
2026-04-17
Start date
2026-03-27
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C00-C97

Interventions

Group 1: Adult oncological patients (=18 years at the time of cancer diagnosis) will be surveyed or interviewed once, regardless of cancer entity and disease stage. This is a multicenter cross-section

Sponsors

Universitätsklinikum Hamburg-Eppendorf
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adults with a cancer diagnosis (= 18 years old) Confirmed cancer diagnosis (regardless of type or stage) Sufficient German language skills to participate in surveys/interviews

Exclusion criteria

Exclusion criteria: Age at cancer diagnosis < 18 years No cancer diagnosis

Design outcomes

Primary

MeasureTime frame
Utilization of a medical second opinion (binary: yes/no). Assessed once at the time of study participation (cross-sectional assessment; recruitment over 12 months). Measured using a study-specific patient questionnaire and supplemented by qualitative interviews.

Secondary

MeasureTime frame
Result of the obtained medical second opinion. Assessed once at study participation among participants reporting utilization of a second opinion; measured using a study-specific patient questionnaire. Time to obtaining a medical second opinion (time from initial treatment recommendation to second opinion appointment and time from appointment to receipt of the second opinion). Assessed once at study participation among participants reporting utilization of a second opinion; measured using a study-specific patient questionnaire.

Countries

Germany

Contacts

Public ContactJonathan Engelke

Universitätsklinikum Hamburg-Eppendorf

j.engelke@uke.de+4915228806508

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026